We injected 5 × 104 highly aggressive MOLM-13-CD1c AML cells i.v. into NSG mice, then 17 days later subjected them to sub-lethal irradiation, followed 24 h later by randomization and i.v. injection of DN4.99 TCR-T cells or vehicle only. The gene discussed is CD1C; the disease is acute myeloid leukemia.